The periosteum contains multipotent cells that can differentiate into osteoblasts and chondrocytes. Cultured periosteum-derived cells (PDCs) have an osteogenic capacity. The purpose of this study was to evaluate the interaction of PDCs with bone graft biomaterial. After cell isolation from the calvarial periosteum of Sprague-Dawley rats, cultured PDCs were placed in critical-sized calvarial defects with beta-tricalcium phosphate (β-TCP). All rats were sacrificed 8 weeks after bone graft surgery, and the bone regenerative ability of bone grafting sides was evaluated by plain radiography, micro-computed tomography (CT), and histological examination. PDCs grafted with β-TCP displayed enhanced calcification in the defect site, density of regenerated bone and new bone formation within the defect and its boundaries. Furthermore, these PDCs more efficiently regenerated new bone as compared to grafted β-TCP only. The results suggest that cultured PDCs have the potential to promote osteogenesis in bone defects.
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I. Introduction
The goal of bone tissue engineering is to induce bone formation in the defect site and develop real bone tissue.
Three essential elements for bone formation by bone tissue engineering are osteoblast-induced bone formation [1] , the use of three-dimensional (3D) scaffolding (especially polymers and bioceramics) to provide proper sites for the ingrowth of cells and vessels, and the use of osteoinductive growth factors to facilitate induction and differentiation of bone tissue [2] .
The importance of periosteum in bone development and fracture healing has been well demonstrated, and the osteogenic potential of cultured periosteal cells has been reported [3] . In the previous study, cultured human periosteum-derived cells showed osteogenic potential in a xenogeneic graft model using rat calvarial defects and showed the possibility of using cultured human periosteal cell/collagen complex grafts to form bone within in-vivo bone defects [3] . However, this new bone did not completely fill the defect by 35 days post grafting.
Therefore, some investigators have suggested the application of bone growth factors [3] and scaffolds [4] are required to enhance osteogenic activity of periosteum- II. Materials and Methods
Animals.
Ten-week-old male Sprague-Dawley rats weighing 250-280 g were used. They were kept under a standard light-dark schedule at a temperature of 20 ± 3oC and 50 ± 10% humidity. Stock diet and tap water were available ad libitum. The care, maintenance and treatment of animals were carried out in accordance with the Guidelines for Animal Experiments of Chonnam National University.
Cells and cell culture.
Periosteum was harvested from the calvarium of9-month-old adult male rats. PDCs were isolated using a standard collagenase digestion protocol. Briefly, cells were Cross, Seoul, Korea). Rats in the control group did not receive a graft. After grafting, the periosteum and skin were surgically closed.
Radiography.
The calvaria were radiographed using a Port-X dental X-ray instrument (Genoray, Seoul, Korea) and a Digi-X Sensor oral sensor (Hanjin Digi-X, Seoul, Korea) under conditions of 70 kVp and 0.15 mAs at 8 weeks after surgery.
Micro-computed tomography (CT).
At post-surgery week 8, all rats were sacrificed and calvaria were collected. Using a Skyscan 1172 Desktop X-ray Microtomograph micro-CT scanner (Skyscan, Aartselaar, Belgium), calvaria were scanned at 50 kV and 200 µA. After scanning, images were analyzed with NRecon Ver.1.4.4 software (Skyscan).
Histology.
The collected calvaria were fixed in 10% neutral formalin and decalcified with formic acid. All the specimens were embedded in paraffin and 5 μm-thick axial sections were obtained. Sections were deparaffinized in xylene, rehydrated in graded alcohol and stained with hematoxylin and eosin.
III. Results
Radiological findings.
In the control group,little new bone was formed from the defect margin and showed only soft tissue-like radiopacities (Fig. 1A) .The defect was almost completely repaired by the graft materials in the autograft group (Fig.   1B ). In β-TCP and β-TCP/PDCs groups, β-TCP particles were radiopaque and round, and their density was variable.
Marginal new bone formation was evident at the defect margin in both groups (Fig. 1C, Fig. 1D ). More pronounced bone formation of the scaffold and the margin of defect were evident in the β-TCP/PDCs group compared to the β-TCP group (Fig. 1C, Fig. 1D ).
Micro-CT findings.
Micro-CT generated coronal tomograms of bone repair in 8 mm critical-size calvarial defects at 8 weeks. In the autograft group, the defect was almost completely repaired by graft materials (Fig. 2) . In the β-TCP and β -TCP/PDCs groups, bone defect boundaries of host bone could be observed, with some remnant β-TCP, and a little new bone formation was observed at the margin of bone defect compared to the autograft group (Fig. 2) . But the bottom margins of 8 mm critical defect were bridged either side in the β-TCP/PDCs group (Fig. 2) .
Histological findings.
In the control group, the bone defect site was filled with soft tissue and blood vessels. A small amount of bone was formed only from existing bone (Fig. 3) . In the autograft group, grafted bone particles were fused and new bone formation occurred with vascularization (Fig. 4) . In the β-TCP grafted group, β-TCP particles absorbed and new bone formation occurred in and out of the β-TCP particles (Fig.5) . Also, the fusion of β-TCP particles and normal bone was evident at the defect margin. In the β -TCP/PDCs group, β-TCP particles absorbed and new bone formation occurred in the β-TCP particles with neovascularization. Also, the fusion of β-TCP particles and normal bone was evident at the defect margin (Fig. 6 ).
IV. Discussion
β-TCP is used for bone tissue engineering due to its good biocompatibility and biodegradability [5] . This study combined cells capable of osteogenetic activity with an appropriate scaffolding material to stimulate bone regeneration and repair. In particular, mesenchymal stem cells have a high proliferation capacity and multilineage potential. They can differentiate into osteoblasts [6] , thus, they have been used to engineer bone tissue. The periosteum is easier to obtain from patients than are bone marrow and periodontium, and the periosteum is a sufficient supply of osteogenic cells [7] , chondrogenic cells [8] and mesenchymal progenitor cells [9] . PDCs may serve as an optimal cell source for tissue engineering based on their accessibility, ability to proliferate rapidly and capability to differentiate into multiple mesenchymal lineages [10] . In our previous study, grafting of β-TCP particles proved to be an efficient means to regenerate new bone in a rat critical-sized calvarial defect model [11] . However, fusion with bone defect margins did not occur. Thus, this study was designed to test the practicality of placing PDCs and β-TCP particles into bone defects and to demonstrate the feasibility of calvarial defect repair using PDCs.
In our results, radiographic and histologic findings revealed near-complete repair of defects by the graft materials in the autograft group. However, in the β-TCP and β-TCP/PDCs groups, β-TCP particles were radiopaque and round, and their density was variable.
Marginal new bone formation of the β-TCP and β -TCP/PDCs groups was evident at the defect margin and around β-TCP particles. In the β-TCP/PDCs group, micro-CT revealed that the bottom margins of 8 mm critical defect were bridged on either side compared the β -TCP group. Also, β-TCP particles had absorbed and new bone formation had occurred in the β-TCP particles, with neovascularization and the fusion of β-TCP particle and normal bone was seen at the defect margin. This indicated that β-TCP has been shown to be an appropriate scaffold for PDCs and to promote bone formation by PDCs.
Many different processing techniques have been developed for the design and fabrication of scaffolds that are required to seed osteoprogenitor cells for tissue regeneration. One study reported that bone formation was observed in the bone defect treated with periosteal cells from cultured medium within 35 days of grafting [3] . As in a previous study [12] , while new bone induced from the grafted tissue was detected in the bone defect, thisnew bone did not completely fill the defect by 35 days post grafting. The scaffold for osteoprogenitor cells serves to promote progenitor cell migration, proliferation and differentiation, as well as vascularization [3] is needed. If more effective bone regeneration is to be achieved, the efficiency of cell introduction into β-TCP needs to be improved. Therefore, PDCs/β-TCP composites were implanted into critical defects using sinus augmentation with fibrin glue mixture. We successfully demonstrated that β-TCP had good biodegradability and osteoconductivity as a scaffold material for bone tissue engineering [5] . Similarly, Matsuno et al. [5] demonstrated that β-TCP bead/mesenchymal stem cells are replaced by bone without any adverse reactions. However, some investigators have suggested the application of bone growth factors is required to enhance osteoblastic differentiation of periosteum-derived cells.
Hanada et al. [13] reported that chondrogenesis of rat periosteal cells is clearly enhanced by tumor growth factor-β and bone morphogenetic protien-2 treatment.
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